Free Trial

Zions Bancorporation National Association UT Makes New $1.91 Million Investment in Stevanato Group S.p.A. (NYSE:STVN)

Stevanato Group logo with Medical background

Key Points

  • Zions Bancorporation National Association UT acquired 93,709 shares of Stevanato Group S.p.A., valued at approximately $1.9 million, indicating growing institutional interest in the stock.
  • Several other institutional investors, including Whittier Trust Co. and Wells Fargo & Company MN, have recently increased their stakes in Stevanato Group, showcasing robust investment activity.
  • Stevanato Group has received a consensus rating of "Moderate Buy" from analysts, with a price target of €25.13 ($29.22), reflecting positive sentiment about its future performance.
  • MarketBeat previews top five stocks to own in October.

Zions Bancorporation National Association UT acquired a new position in Stevanato Group S.p.A. (NYSE:STVN - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 93,709 shares of the company's stock, valued at approximately $1,914,000.

Several other institutional investors have also added to or reduced their stakes in the company. LPL Financial LLC raised its stake in shares of Stevanato Group by 24.6% during the fourth quarter. LPL Financial LLC now owns 85,721 shares of the company's stock valued at $1,940,000 after acquiring an additional 16,915 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Stevanato Group by 680.3% during the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock valued at $71,000 after acquiring an additional 2,830 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Stevanato Group during the fourth quarter valued at approximately $5,754,000. Advisors Capital Management LLC raised its stake in shares of Stevanato Group by 1.0% during the fourth quarter. Advisors Capital Management LLC now owns 170,776 shares of the company's stock valued at $3,721,000 after acquiring an additional 1,735 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its stake in shares of Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock valued at $162,000 after acquiring an additional 4,965 shares in the last quarter.

Stevanato Group Stock Up 0.3%

STVN stock traded up €0.06 ($0.07) during trading on Wednesday, hitting €21.89 ($25.45). 161,790 shares of the company's stock traded hands, compared to its average volume of 340,592. The business has a fifty day simple moving average of €24.52 and a two-hundred day simple moving average of €22.45. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25. Stevanato Group S.p.A. has a 1 year low of €17.12 ($19.91) and a 1 year high of €28.00 ($32.56). The firm has a market capitalization of $6.63 billion, a P/E ratio of 40.54, a PEG ratio of 2.06 and a beta of 0.55.

Analysts Set New Price Targets

Several equities analysts recently issued reports on STVN shares. William Blair reissued an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. Stephens raised shares of Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of €25.13 ($29.22).

Check Out Our Latest Stock Report on Stevanato Group

Stevanato Group Company Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

See Also

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines